Agency / Source: Q1 Productions

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

3rd Annual Pharmaceutical Managed Markets & Payer Marketing Strategies Conference - Session Topics Include Progression of Medicare Programs and Streamlining Medical Benefit Management Process - Q1Productions.com
3rd Annual Pharmaceutical Managed Markets & Payer Marketing Strategies Conference

 

PRZOOM - /newswire/ - Chicago, IL, United States, 2014/04/03 - Session Topics Include Progression of Medicare Programs and Streamlining Medical Benefit Management Process - Q1Productions.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

For the third consecutive year, Q1 Productions is hosting the Pharmaceutical Managed Markets and Payer Marketing Strategies Conference, providing an inside look at best practices to accommodate changing coverage trends and developing new relationships with the rising number of ACOs. This year’s conference will be held July 14-15, 2014 in Chicago, Illinois.

In keeping with current trends in managed markets and payer marketing, a variety of session topics are scheduled, including working with ACOs, medical benefit management, state health plan marketplaces, and evaluation parameters. Attendees will participate in various networking opportunities with senior and VP level executives from some of the largest biotechnology and pharmaceutical companies and take part in interactive workshops focusing on deployment and training strategies within today’s healthcare landscape. By popular request, more payers will be presenting sessions, including Michael Katzman of Blue Cross Blue Shield of Massachusetts, Matt Salner of Access Health CT, and Glenda Flemister of Aetna.

During this conference, attendees will explore the changing coverage trends under Medicare, including the current regulations surrounding Medicare Advantage and Part D prescriptions program. Under tight federal budget scrutiny, CMS is continually striving to improve payment margins and program competencies; the newly released modifications have the potential to reduce Medicare expenditures by roughly $1.3 billion by 2019. Meenakshi Datta of Sidley Austin LLP, and Karen Gibbs of McDermott, Will & Emery will lead a discussion highlighting coverage changes, impact of stringent negotiated pricing restrictions, and incorporating CMS changes in payer negotiation and pricing.

About the Organizer

Q1 Productions (q1productions.com) designs and develops webinars, training courses, conference programs and forums aimed at specifically targeted audiences throughout highly regulated industries in order to provide strategic learning and timely program content. Through a highly structured production process focused on research calls with end-users and key stakeholders in the industry, our team is able to understand the immediate business concerns of today’s leading executives. Whether focusing on new or pending legislative and health policy issues or enhanced technologies or processes that will drive efficiency, our programs provide solutions to the urgent educational and information needs of our attendees.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Q1 Productions

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


3rd Annual Pharmaceutical Managed Markets & Payer Marketing Strategies Conference

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Paul Hernandez - Q1Productions.com 
312-602-9684 eabdnour[.]q1productions.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Q1 Productions securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Press Releases From Q1 Productions / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Press Releases:

Ono Pharma Enters into a Drug Discovery Partnership with Mediar Therapeutics to Create Novel Antibody Therapeutics for Fibro-inflammatory Diseases
OPDIVO® Intravenous Infusion Approved in South Korea for the Treatment of Resectable Non-Small Cell Lung Cancer
Ipsen Completes Acquisition of Memo Therapeutics AG, Adding First-in-class Asset to Ipsen’s Rare Disease Pipeline
SCHOTT Pharma and Nemera Deliver Verified Pen Injector Platform with Sterile Cartridge System
IQIRVO® Demonstrates Statistically Significant Improvement in ALP Normalization in Patients with PBC in Phase IIIb ELSPIRE Study
Dysport® is the First Botulinum Toxin to Achieve Positive Topline Phase III Results in Both Episodic and Chronic Migraine
STEMCELL Technologies and CCRM Partner to Expand Access to Matched GMP and RUO iPSC Lines for Cell Therapy Development
Ipsen to Acquire Memo Therapeutics AG - Adding First-in-class BK Polyomavirus Antibody, Expanding Rare Disease Portfolio
Ipsen to Acquire Kartos Therapeutics, Expanding Hemato-oncology Late-stage Pipeline
Ono Pharma Submits a Supplemental Application in Japan to Expand the Use of VELEXBRU® Tablets for the Treatment of Central Nervous System Involvement

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
.



PREMIUM Members


Visit BizJobs.com

Visit  JobsWare.com

Visit  La Bella Bakery Artisan Bakery Arizona







 
  ©2005-2026 PRZOOM - Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today